How Dangerous Is It for Lung Cancer Patients to Skip Radiation Treatments?
TUESDAY, Oct. 25, 2022 (HealthDay News) — As doctors work toward developing more personalized cancer care, a new study looks at whether lung cancer patients can miss a few days of radiation treatment and make them up with a higher dose. The more trea…
Learn MoreEl pedido de un fármaco para la enfermedad por radiación no se relaciona con Ucrania: autoridades de salud
LUNES, 10 de octubre de 2022 (HealthDay News) — Aunque hace poco que Estados Unidos hizo un pedido de 290 millones de dólares en suministros de un medicamento para tratar la enfermedad por radiación, las autoridades de salud federales afirman que est…
Learn MoreOrder of Radiation Sickness Drug Unrelated to Recent Events in Ukraine
TUESDAY, Oct. 11, 2022 (HealthDay News) — While the United States has recently ordered a $290 million supply of a drug meant to treat radiation sickness, federal health officials say that is not cause for alarm.It is coincidental that the order of Np…
Learn MoreOrder of Radiation Sickness Drug Unrelated to Recent Events in Ukraine, U.S. Health Officials Say
MONDAY, Oct. 10, 2022 (HealthDay News) – While the United States has recently ordered a $290 million supply of a drug meant to treat radiation sickness, federal health officials say that’s not cause for alarm.It’s coincidental that the order of Nplate…
Learn MoreParticle Radioactivity in Air Pollution Tied to CVD Mortality
WEDNESDAY, Oct. 5, 2022 (HealthDay News) — Particle radioactivity, measured as gross β activity from highly resolved spatiotemporal predictions, is associated with increased cardiovascular disease (CVD) mortality, according to a study published onlin…
Learn MoreASTRO Offers Guidance on RT for IDH-Mutant Diffuse Grade 2, 3 Glioma
MONDAY, Sept. 19, 2022 (HealthDay News) — In a clinical practice guideline issued by the American Society for Radiation Oncology and published in the September-October issue of Practical Radiation Oncology, recommendations are presented for the use o…
Learn MoreRural Residence Tied to Poorer Adherence to RT for Cancer
WEDNESDAY, Aug. 24, 2022 (HealthDay News) — Rural residence is associated with both radiation treatment (RT) nonadherence and poorer overall survival among cancer patients, according to a study recently published in the International Journal of Radia…
Learn MoreNeoadjuvant mFOLFIRINOX Studied for Borderline Resectable PDAC
WEDNESDAY, Aug. 3, 2022 (HealthDay News) — For patients with borderline resectable pancreatic ductal adenocarcinoma (PDAC), favorable overall survival was observed following treatment with eight cycles of neoadjuvant modified FOLFIRINOX (mFOLFIRINOX)…
Learn MoreNeoadjuvant mFOLFIRINOX Studied for Borderline Resectable PDAC
WEDNESDAY, Aug. 3, 2022 (HealthDay News) — For patients with borderline resectable pancreatic ductal adenocarcinoma (PDAC), favorable overall survival was observed following treatment with eight cycles of neoadjuvant modified FOLFIRINOX (mFOLFIRINOX)…
Learn More